There is currently no uniform definition of cutaneous lupus erythematosus (CLE) upon which to base a study population for observational and interventional trials. A preliminary questionnaire was derived from and sent to a panel of CLE experts which demonstrated consensus agreement that (1) there is a need for new definitions for CLE (2) CLE is distinct from systemic lupus erythematosus and that a CLE grouping scheme should remain apart from current systemic lupus erythematosus schema (3) current CLE grouping schemes are inadequate around communication, prognostic information and to meet the needs of researchers, clinicians, patients and payers
INTRODUCTION: Systemic lupus erythematosus (SLE) is an autoimmune disease with multiorgan involveme...
AbstractTo inform our ongoing efforts to develop defining features to be incorporated into a novel s...
Objective: The European League Against Rheumatism and the American College of Rheumatology jointly e...
There is currently no uniform definition of cutaneous lupus erythematosus (CLE) upon which to base a...
AbstractCurrently, no standardized classification criteria exist for cutaneous lupus erythematosus. ...
Abstract A study group of the European Society of Cutaneous Lupus Erythematosus (EUSCLE) develope...
Cutaneous lupus erythematosus (CLE) is a clinically heterogeneous group of rare skin dis-eases that ...
OBJECTIVE: The diagnosis and treatment of the mucocutaneous (MC), neuropsychiatric (NP), and renal (...
Cutaneous Lupus Erythematosus (CLE) is a clinically diverse group of autoimmune skin diseases with s...
Currently, no standardized classification criteria exist for cutaneous lupus erythematosus. With inc...
Currently, no standardized classification criteria exist for cutaneous lupus erythematosus. With inc...
OBJECTIVES: Treat-to-target recommendations have identified 'remission' as a target in systemic lupu...
We developed and validated a measurement instrument (CLASI—Cutaneous Lupus Erythematosus Disease Are...
Incomplete systemic lupus (iSLE) is an acknowledged condition of patients with clinical signs of lup...
Kutani eritemski lupus (CLE) obuhvaća širok spektar dermatoloških manifestacija, koje mogu ili ne mo...
INTRODUCTION: Systemic lupus erythematosus (SLE) is an autoimmune disease with multiorgan involveme...
AbstractTo inform our ongoing efforts to develop defining features to be incorporated into a novel s...
Objective: The European League Against Rheumatism and the American College of Rheumatology jointly e...
There is currently no uniform definition of cutaneous lupus erythematosus (CLE) upon which to base a...
AbstractCurrently, no standardized classification criteria exist for cutaneous lupus erythematosus. ...
Abstract A study group of the European Society of Cutaneous Lupus Erythematosus (EUSCLE) develope...
Cutaneous lupus erythematosus (CLE) is a clinically heterogeneous group of rare skin dis-eases that ...
OBJECTIVE: The diagnosis and treatment of the mucocutaneous (MC), neuropsychiatric (NP), and renal (...
Cutaneous Lupus Erythematosus (CLE) is a clinically diverse group of autoimmune skin diseases with s...
Currently, no standardized classification criteria exist for cutaneous lupus erythematosus. With inc...
Currently, no standardized classification criteria exist for cutaneous lupus erythematosus. With inc...
OBJECTIVES: Treat-to-target recommendations have identified 'remission' as a target in systemic lupu...
We developed and validated a measurement instrument (CLASI—Cutaneous Lupus Erythematosus Disease Are...
Incomplete systemic lupus (iSLE) is an acknowledged condition of patients with clinical signs of lup...
Kutani eritemski lupus (CLE) obuhvaća širok spektar dermatoloških manifestacija, koje mogu ili ne mo...
INTRODUCTION: Systemic lupus erythematosus (SLE) is an autoimmune disease with multiorgan involveme...
AbstractTo inform our ongoing efforts to develop defining features to be incorporated into a novel s...
Objective: The European League Against Rheumatism and the American College of Rheumatology jointly e...